Neuro-Oncology DIPG-31 Prognostic and predictive biomarkers for H3K27M-altered diffuse intrinsic pontine glioma from PNOC003


Diffuse intrinsic pontine glioma (DIPG) is a fatal brain tumor. Herein, we report on novel prognostic and predictive genomic biomarkers identified in PNOC003, a multi-center precision medicine trial for children and young adults diagnosed with DIPG.


Previous
Previous

Bay Area Doctor Leads Global Collaboration to Accelerate Cures for the Deadliest Childhood Cancer

Next
Next

Journal of Neurosurgery Liquid biopsy for diffuse intrinsic pontine glioma: an update